Citizen Health, a company that helps patients oversee rare and complex health conditions, announced it raised $14.5 million in seed funding.Transformation Capital led the round with participation from Wavemaker 360 and prominent angel investors.
The…
What You Should Know:
– NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.
– The framework provides a powerful suite…
Continue Reading
What You Should Know:
– Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients, announced today a further equity investment from NVentures, NVIDIA’s venture capital arm.
– This investment is in addition…
Continue Reading
Taylor Wirth, Partner at Barnes & Thornburg
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth,…
Continue Reading
What You Should Know:
– Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development, today announced a collaboration with Google Cloud to develop a cutting-edge foundation…
Continue Reading
What You Should Know:
– Accenture has made a strategic investment, through Accenture Ventures, in 1910 Genetics, a biotechnology company revolutionizing drug discovery with its AI-powered platform. Terms of the investment were not disclosed.
– The…
Continue Reading
What You Should Know:
– Quris-AI, a leading Bio-AI company revolutionizing drug development, has acquired Nortis, a pioneer in microphysiology systems (MPS) technology, formerly known as Numa Biosciences.
– The strategic acquisition will integrate Nortis’s advanced…
Continue Reading
What You Should Know:
– Frontier Bio Corporation has successfully created complex microscale lung tissue by combining 3D bioprinting with the self-assembling capabilities of stem cells, mirroring the natural organ development process.
– Frontier Bio’s breakthrough…
Continue Reading
What You Should Know:
– Gilead Sciences, a global biopharmaceutical company, and Genesis Therapeutics, an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.
– The startegic partnership leverages…
Continue Reading
What You Should Know:
– Kahun, a pioneer in medical knowledge structuring, has introduced a new AI Agent specifically designed for the pharmaceutical industry.
– The AI Agent aims to bridge the gap between medical knowledge…
Continue Reading
